Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy.
Aykut EliçoraBüşra Yaprak BayrakÇiğdem VuralHuseyin Fatih SezerSemra Uzun ErkalElif MetinPublished in: Journal of cardiothoracic surgery (2024)
All cell types of innate and adaptive intratumoral immunity can affect lung cancer tissues simultaneously, and these interactions have a very complex structure. Understanding the tumor microenvironment and the different roles of associated cancer immune cells may lead to the discovery of new targets for immunological therapies and increased survival times in lung cancer.
Keyphrases
- neoadjuvant chemotherapy
- end stage renal disease
- immune response
- ejection fraction
- locally advanced
- chronic kidney disease
- newly diagnosed
- gene expression
- lymph node
- single cell
- papillary thyroid
- small molecule
- sentinel lymph node
- prognostic factors
- high throughput
- cell therapy
- stem cells
- early stage
- nk cells
- patient reported outcomes
- mesenchymal stem cells
- young adults
- bone marrow
- free survival
- patient reported